• 제목/요약/키워드: PCI

검색결과 487건 처리시간 0.039초

SystemC를 이용한 PCI Express 종단장치 코어의 검증 모델 설계 (Design of PCI Express Endpoint Core Verification Model Using SystemC)

  • 김선욱;김영우;박경
    • 대한전자공학회:학술대회논문집
    • /
    • 대한전자공학회 2003년도 컴퓨터소사이어티 추계학술대회논문집
    • /
    • pp.167-170
    • /
    • 2003
  • In this paper, a design and experiment of PCI Express Core verification Model is described. The model targeting Endpoint core verification is designed by using newly-emerging SystemC which is a system design language based on a new C++ class library and simulation engine. In the verification model, we developed a SystemC Host System model which act as a Root Complex and Device Driver dedicated to the PCI Express Endpoint RTL Core. The test of Host System Model is guided by scenarios which implements and acts point of Device Driver and Root Complex and shows the result of simulation. Also, We present the full structure of verification model and Host model.

  • PDF

계수이산 공정에서 SPC 관리도에 의한 Z 시그마 수준과 PCI 및 PPI의 산출 (Calculation of Z Sigma Level, PCI, and PPI By SPC Charts in the Discrete Process)

  • 최성운
    • 대한안전경영과학회지
    • /
    • 제11권1호
    • /
    • pp.131-136
    • /
    • 2009
  • The research develops the calculation steps of Z sigma level, process capability index(PCI) and process performance index(PPI) applicable to the discrete process in the service industry. The paper presents three following topics used related process indexes according to the precision and accuray in the continuous process. The contents include diverse process indexs for nonconformities by SPC attribute control charts and bias coefficient. The same technique of the nonconformites is also used in the nonconforming units. The practical examples are provided to help easier understanding for users.

PCI시술시 혈소판 당단백 GP IIb/IIIA 억제제(Abciximab) 투여의 경제적 가치 (Economic Value of Platelet Glycoprotein IIb/IIIA Receptor Blocker (Abciximab) for Percutaneous Coronary Intervention)

  • 김진현;신상진;김은주;이영희
    • 약학회지
    • /
    • 제51권3호
    • /
    • pp.186-193
    • /
    • 2007
  • This study was performed to analyse the economic value of abciximab which is used in PCI to prevent high-risk patients with ischemic complications. The effectiveness of abciximab was extracted from published clinical trials by search-ing CCIS, and the direct medical costs relevant to using abciximab were estimated from the NHI claims database. The results in terms of cost per life-year gained (LYG) and cost per QALY gained showed that abciximab was cost-effective enough to deserve its cost. Social net benefit resulting from abciximab in PCI was estimated to be 60-70 billion Won per year.

The Use of System for Design Verification of PCI Express Endpoint RTL Core

  • Kim Sun-Wook;Kim Young-Woo;Park Kyoung
    • 대한전자공학회:학술대회논문집
    • /
    • 대한전자공학회 2004년도 ICEIC The International Conference on Electronics Informations and Communications
    • /
    • pp.285-288
    • /
    • 2004
  • In this paper, we present a design and experiment of PCI Express core verification model. The model targeting Endpoint core based on Verilog HDL is designed by newly-emerging SystemC, which is a new C++ class library based system design approach. In the verification model, we designed and implemented a SystemC host system model which acted as Root Complex and device driver dedicated to the PCI Express Endpoint RTL core. The verification process is scheduled by scenarios which are implemented in host model. We show that the model is useful especially for verifying the RTL model which has dependencies on system software.

  • PDF

Recent advances in utilization of photochemical internalization (PCI) for efficient nano carrier mediated drug delivery

  • Park, Wooram;Park, Sin-Jung;Lee, Jun;Na, Kun
    • Biomaterials and Biomechanics in Bioengineering
    • /
    • 제2권1호
    • /
    • pp.1-13
    • /
    • 2015
  • Despite recent progresses in nanoparticle-based drug delivery systems, there are still many unsolved limitations. Most of all, a major obstacle in current nanoparticle-based drug carrier is the lack of sufficient drug delivery into target cells due to various biological barriers, such as: extracellular matrix, endolysosomal barrier, and drug-resistance associated proteins. To circumvent these limitations, several research groups have utilized photochemical internalization (PCI), an extension of photodynamic therapy (PDT), in design of innovative and efficient nano-carriers drug delivery. This review presents an overview of a recent research on utilization of PCI in various fields including: anti-cancer therapy, protein delivery, and tissue engineering.

만성 뇌졸중 환자의 임상적 특성이 보행 시 생리적 부담지수에 미치는 영향 (The Effects of Clinical Characteristics of Chronic Stroke Patients on Physiological Cost Index During Walking)

  • 김원호
    • 한국전문물리치료학회지
    • /
    • 제13권1호
    • /
    • pp.32-37
    • /
    • 2006
  • The purpose of this study was to investigate the effects of clinical characteristics of chronic stroke patients on physiological cost index (PCI) during walking. Fourteen stroke patients participated in this study. To investigate the clinical characteristics, Fugl-Meyer score (FMS), gait velocity (GV), muscle strength of the knee extensor, modified Ashworth scale (MAS) of ankle plantar flexor, devices, and gait patterns during walking were measured and analyzed. The results were as follows: Firstly, use of devices and high MAS of the ankle plantar flexor significantly increased PCI. Secondly, PCI was significantly correlated with the FMS and MAS of the ankle plantar flexor. In conclusion, inhibition of spasticity of the ankle plantar flexor is considered to reduce PCI during walking for chronic stroke patients.

  • PDF

SCI 기반 PC 클러스터링을 위한 CC-NUMA 프로토타입 카드의 설계와 성능 (Design and Performance of a CC-NUMA Prototype Card for SCI-Based PC Clustering)

  • 오수철;정상화
    • 한국정보과학회논문지:시스템및이론
    • /
    • 제29권1호
    • /
    • pp.35-41
    • /
    • 2002
  • 고성능 PC 클러스터 시스템을 구축하기 위해서는 네트워크 접근시간을 최소화하는 것이 중 요하다. SCI 기반 PC 클러스터 시스템에서는 각 노드에 네트워크 캐쉬를 유지함으로써 네트워크 접근 시 간을 줄이는 것이 가능하다. 본 논문에서는 SCI 기반 PC 클러스터 시스템을 위해서 네트워크 캐쉬를 활용하는 CC-NUMA 카드를 제안한다. CC-NUMA 카드는 각 노드의 PCI 슬롯(slot)에 plug-in 되는 형태이며 공유메모리 네트워크 캐쉬 네트워크 제어 모듈을 포함한다. 네트워크 캐쉬는 클러스터 노드의 PCI 버스상에서 존재하는 공유메모리를 캐쉬하여 공유메모리와 네트워크 캐쉬 사이의 일관성은 IEEC SCI 표준 에 의해 유지된다. 본 연구에서는 SCI 기반 PC 클러스터 시스템의 성능을 측정하기 위하여 CC-NUMA 프로토타입 카드를 개발하였으며, 이를 기반으로 하여 클러스터 시스템을 구축하였다. 실험결과. CC- NUMA 카드를 장착한 클러스터 시스템이 네트워크 캐쉬를 활용하지 않는 NUMA 기반 클러스터 시스템 에 비해서 우수한 성능을 보임을 알 수 있었다.

The Prevalence of Cardiovascular Disease Risk Factors and the Framingham Risk Score in Patients Undergoing Percutaneous Intervention Over the Last 17 Years by Gender: Time-trend Analysis From the Mayo Clinic PCI Registry

  • Lee, Moo-Sik;Flammer, Andreas J.;Kim, Hyun-Soo;Hong, Jee-Young;Li, Jing;Lennon, Ryan J.;Lerman, Amir
    • Journal of Preventive Medicine and Public Health
    • /
    • 제47권4호
    • /
    • pp.216-229
    • /
    • 2014
  • Objectives: This study aims to investigate trends of cardiovascular disease (CVD) risk factor profiles over 17 years in percutaneous coronary intervention (PCI) patients at the Mayo Clinic. Methods: We performed a time-trend analysis within the Mayo Clinic PCI Registry from 1994 to 2010. Results were the incidence and prevalence of CVD risk factors as estimate by the Framingham risk score. Results: Between 1994 and 2010, 25 519 patients underwent a PCI. During the time assessed, the mean age at PCI became older, but the gender distribution did not change. A significant trend towards higher body mass index and more prevalent hypercholesterolemia, hypertension, and diabetes was found over time. The prevalence of current smokers remained unchanged. The prevalence of ever-smokers decreased among males, but increased among females. However, overall CVD risk according to the Framingham risk score (FRS) and 10-year CVD risk significantly decreased. The use of most of medications elevated from 1994 to 2010, except for ${\beta}$-blockers and angiotensin converting enzyme inhibitors decreased after 2007 and 2006 in both baseline and discharge, respectively. Conclusions: Most of the major risk factors improved and the FRS and 10-year CVD risk declined in this population of PCI patients. However, obesity, history of hypercholesterolemia, hypertension, diabetes, and medication use increased substantially. Improvements to blood pressure and lipid profile management because of medication use may have influenced the positive trends.